Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-08-08
Sharma Mani Files AstraZeneca PLC American Depositary Shares (AZN) Form 4 - August 08, 2026
Sharma Mani bought 21 AZN shares worth $3.4K in this Form 4 filing, reported to the SEC on 2026-08-08.
- Insider
- Sharma Mani
- Issuer
- AstraZeneca PLC American Depositary Shares AZN · NASDAQ
- Filed
- Period
- 2026-08-08
- Accession
- 0001104659-26-107055
- Source
- Official filing on sec.gov ↗
Transactions (2)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Sharma Mani | 2026-09-08 | Buy | 1 | $162.60 | $162.60 | Direct |
| Sharma Mani | 2026-08-08 | Buy | 20 | $160.57 | $3.2K | Direct |
| Net change | +21 | +$3.4K | ||||
About AstraZeneca PLC American Depositary Shares
AstraZeneca PLC American Depositary Shares is the U.S.-traded representation of AstraZeneca PLC, a global biopharmaceutical company focused on the discovery, development, manufacture, and commercialization of prescription medicines. The company serves major therapeutic areas including oncology, cardiovascular, renal and metabolic diseases, respiratory and immunology, and rare diseases, with a portfolio that spans both established treatments and specialty medicines. AstraZeneca also operates in biologics and small-molecule research, supporting a broad pipeline of medicines used across hospitals, clinics, and specialty care settings. Its business model centers on developing therapies for patients and supplying healthcare systems and providers worldwide. Founded in 1999 and headquartered in Cambridge, United Kingdom, AstraZeneca is a significant participant in the global pharmaceutical market through its diversified drug portfolio and research-driven operations.
Track AZN insider activity
Get alerted when AstraZeneca PLC American Depositary Shares executives buy or sell their shares.